Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Condylomata Acuminata × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1063 Neoplasms 865 Carcinoma, Non-Small-Cell Lung 717 Prostatic Neoplasms 635 Colorectal Neoplasms 487 Lung Neoplasms 472 Neoplasm Metastasis 362 Multiple Myeloma 346 Leukemia, Myeloid, Acute 331 Ovarian Neoplasms 317 Melanoma 300 Pancreatic Neoplasms 279 Squamous Cell Carcinoma of Head and Neck 244 Recurrence 226 Brain Neoplasms 223 Carcinoma, Hepatocellular 219 Stomach Neoplasms 215 Endometrial Neoplasms 197 Glioblastoma 196 Uterine Cervical Neoplasms 193 Lymphoma 190 Precursor Cell Lymphoblastic Leukemia-Lymphoma 189 Head and Neck Neoplasms 185 Urinary Bladder Neoplasms 183 Triple Negative Breast Neoplasms 183 Carcinoma, Renal Cell 175 Leukemia, Lymphocytic, Chronic, B-Cell 160 Hematologic Neoplasms 159 Lymphoma, Non-Hodgkin 156 Glioma 155

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Hepatitis B Vaccines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02750202 2026-01-23

TheraVACCS

University of Pretoria

Phase 3 Completed

52 enrolled 34 charts

Condylomata Acuminata

Data powered by HemOnc (CC BY 4.0) Colophon ⚡